BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Chen TT, Lv JJ, Chen L, Li M, Liu LP. Heparanase inhibition leads to improvement in patients with acute gastrointestinal injuries induced by sepsis. World J Gastroenterol 2023; 29(35): 5154-5165 [PMID: 37744293 DOI: 10.3748/wjg.v29.i35.5154]
URL: https://www.wjgnet.com/1007-9327/full/v29/i35/5154.htm
Number Citing Articles
1
Di Chen, Lin-Jun Wang, Hong-Lei Li, Fei Feng, Jian-Chun Li, Liping Liu. Progress of heparanase in septic cardiomyopathy: A reviewMedicine 2024; 103(33): e38901 doi: 10.1097/MD.0000000000038901
2
Di Chen, Honglei Li, Shitao Huang, Zhongya Huang, Yibo Sun, Liping Liu. Heparanase inhibitor improves clinical study in patients with septic cardiomyopathyFrontiers in Medicine 2024; 11 doi: 10.3389/fmed.2024.1429109
3
Tingting Tan, Jiajie Li, Wensi Fan, Kangni Shang, Chujun Yang, Xiaohao Liu, Shihui Zhu, Tong Liu, Junjie Wang, Yingchuan Li, Yunfeng Lin. Tetrahedral Framework Nucleic Acid Relieves Sepsis‐Induced Intestinal Injury by Regulating M2 MacrophagesCell Proliferation 2025;  doi: 10.1111/cpr.13803